Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Effects of treatment for tobacco dependence on resting cerebral glucose metabolism.

Costello MR, Mandelkern MA, Shoptaw S, Shulenberger S, Baker SK, Abrams AL, Xia C, London ED, Brody AL.

Neuropsychopharmacology. 2010 Feb;35(3):605-12. doi: 10.1038/npp.2009.165. Epub 2009 Oct 28.

2.

Treatment for tobacco dependence: effect on brain nicotinic acetylcholine receptor density.

Brody AL, Mukhin AG, Stephanie Shulenberger, Mamoun MS, Kozman M, Phuong J, Neary M, Luu T, Mandelkern MA.

Neuropsychopharmacology. 2013 Jul;38(8):1548-56. doi: 10.1038/npp.2013.53. Epub 2013 Feb 21.

3.

Attenuation of cue-induced cigarette craving and anterior cingulate cortex activation in bupropion-treated smokers: a preliminary study.

Brody AL, Mandelkern MA, Lee G, Smith E, Sadeghi M, Saxena S, Jarvik ME, London ED.

Psychiatry Res. 2004 Apr 30;130(3):269-81. Erratum in: Psychiatry Res. 2004 Dec 15;132(2):183-4.

4.

Attenuation of cue-induced smoking urges and brain reward activity in smokers treated successfully with bupropion.

Weinstein A, Greif J, Yemini Z, Lerman H, Weizman A, Even-Sapir E.

J Psychopharmacol. 2010 Jun;24(6):829-38. doi: 10.1177/0269881109105456. Epub 2009 Jul 31.

PMID:
19648219
5.

Smoking-induced change in intrasynaptic dopamine concentration: effect of treatment for Tobacco Dependence.

Brody AL, London ED, Olmstead RE, Allen-Martinez Z, Shulenberger S, Costello MR, Abrams AL, Scheibal D, Farahi J, Shoptaw S, Mandelkern MA.

Psychiatry Res. 2010 Sep 30;183(3):218-24. doi: 10.1016/j.pscychresns.2009.06.004. Epub 2010 Aug 3.

6.

Brain glucose metabolism difference between bipolar and unipolar mood disorders in depressed and euthymic states.

Hosokawa T, Momose T, Kasai K.

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Mar 17;33(2):243-50. doi: 10.1016/j.pnpbp.2008.11.014. Epub 2008 Dec 3.

PMID:
19100808
7.

Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.

Alexander GE, Chen K, Pietrini P, Rapoport SI, Reiman EM.

Am J Psychiatry. 2002 May;159(5):738-45.

PMID:
11986126
8.

Postoperative alteration of cerebral glucose metabolism in mesial temporal lobe epilepsy.

Joo EY, Hong SB, Han HJ, Tae WS, Kim JH, Han SJ, Seo DW, Lee KH, Hong SC, Lee M, Kim S, Kim BT.

Brain. 2005 Aug;128(Pt 8):1802-10. Epub 2005 May 4.

PMID:
15872014
9.

Effects of nicotine on regional cerebral glucose metabolism in awake resting tobacco smokers.

Domino EF, Minoshima S, Guthrie SK, Ohl L, Ni L, Koeppe RA, Cross DJ, Zubieta J.

Neuroscience. 2000;101(2):277-82.

PMID:
11074150
11.
12.

Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology.

Laforce R Jr, Tosun D, Ghosh P, Lehmann M, Madison CM, Weiner MW, Miller BL, Jagust WJ, Rabinovici GD.

Neuroimage Clin. 2014 Mar 19;4:508-16. doi: 10.1016/j.nicl.2014.03.005. eCollection 2014.

13.

18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.

Knopman DS, Jack CR Jr, Wiste HJ, Lundt ES, Weigand SD, Vemuri P, Lowe VJ, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Roberts RO, Boeve BF, Petersen RC.

Neurobiol Aging. 2014 Sep;35(9):2096-106. doi: 10.1016/j.neurobiolaging.2014.03.006. Epub 2014 Mar 11.

14.

Characterizing the normative profile of 18F-FDG PET brain imaging: sex difference, aging effect, and cognitive reserve.

Yoshizawa H, Gazes Y, Stern Y, Miyata Y, Uchiyama S.

Psychiatry Res. 2014 Jan 30;221(1):78-85. doi: 10.1016/j.pscychresns.2013.10.009. Epub 2013 Oct 31.

PMID:
24262800
15.

Effect of bupropion treatment on brain activation induced by cigarette-related cues in smokers.

Culbertson CS, Bramen J, Cohen MS, London ED, Olmstead RE, Gan JJ, Costello MR, Shulenberger S, Mandelkern MA, Brody AL.

Arch Gen Psychiatry. 2011 May;68(5):505-15. doi: 10.1001/archgenpsychiatry.2010.193. Epub 2011 Jan 3.

16.

Effects of brain amyloid deposition and reduced glucose metabolism on the default mode of brain function in normal aging.

Kikuchi M, Hirosawa T, Yokokura M, Yagi S, Mori N, Yoshikawa E, Yoshihara Y, Sugihara G, Takebayashi K, Iwata Y, Suzuki K, Nakamura K, Ueki T, Minabe Y, Ouchi Y.

J Neurosci. 2011 Aug 3;31(31):11193-9. doi: 10.1523/JNEUROSCI.2535-11.2011.

17.

Changes in regional brain glucose metabolism measured with F-18-FDG-PET in essential tremor.

Ha SW, Yang YS, Song IU, Chung YA, Oh JK, Chung SW.

Acta Radiol. 2015 Apr;56(4):482-6. doi: 10.1177/0284185114531414. Epub 2014 Apr 29.

PMID:
24782572
18.

Impaired cerebral glucose metabolism in prodromal Alzheimer's disease differs by regional intensity normalization.

Küntzelmann A, Guenther T, Haberkorn U, Essig M, Giesel F, Henze R, Schroeter ML, Schröder J, Schönknecht P.

Neurosci Lett. 2013 Feb 8;534:12-7. doi: 10.1016/j.neulet.2012.11.026. Epub 2012 Nov 23.

PMID:
23182881
19.

Glucose metabolism in the primary auditory cortex of postlingually deaf patients: an FDG-PET study.

Okuda T, Nagamachi S, Ushisako Y, Tono T.

ORL J Otorhinolaryngol Relat Spec. 2013;75(6):342-9. doi: 10.1159/000357474. Epub 2014 Jan 10.

PMID:
24435067
20.

Post-carotid endarterectomy changes in cerebral glucose metabolism on (18)F-fluorodeoxyglucose positron emission tomography associated with postoperative improvement or impairment in cognitive function.

Yoshida K, Ogasawara K, Saura H, Saito H, Kobayashi M, Yoshida K, Terasaki K, Fujiwara S, Ogawa A.

J Neurosurg. 2015 Dec;123(6):1546-54. doi: 10.3171/2014.12.JNS142339. Epub 2015 Jul 31.

PMID:
26230467

Supplemental Content

Support Center